FDA's Woodcock on New Unit to Boost Drug Oversight

Feb. 14 (Bloomberg) -- Janet Woodcock, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, speaks about the agency's decision to form a new unit to improve the FDA's scrutiny of brand-name, generic and over-the-counter drugs. Woodcock speaks at the Bloomberg 2014 State of Health Care summit in New York. (Source: Bloomberg)

Tillerson Urges U.N. Council to Act Before N. Korea Does
46:20 - U.S. Secretary of State Rex Tillerson discusses U.S.-North Korea relations in front of the U.N. Security Council. (Source: Bloomberg)
  • Trump Signs Order to Expand Offshore Drilling
  • Can Amazon’s Winning Sales Streak Be Stopped?
  • Trump's Biggest Successes and Failures Thus Far